BILLS-118hr5958ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (19)
5958
2021
2018
2023
30-day
2011
Between 2016 and 2018
one-month’s
later than 1 year
2020
1ST SESSION H. R. 5958
2004
2013
2019
2017
OCTOBER 25
OCTOBER 13
2012
EVENT (1)
the ‘‘
FAC (9)
PO 00000
Frm 00007
PO 00000
Frm 00010
PO 00000
Frm 00011
Fmt
PO 00000
Frm 00009
PO 00000
Frm 00006
PO 00000
Frm 00001
PO 00000
Frm 00004
PO 00000
Frm 00008
Fmt
PO 00000
Frm
GPE (4)
Iowa
the United States
24
States
the United States of America
NORP (2)
American
Americans
ORG (28)
Medicare
WAC
SEC
CONGRESS
Government Accountability Office
the American Medical Association
Fed
Medicaid Services
Oncologist
The Centers for Medicare & Medicaid
United
the Annual Review of Public Health
the Food and Drug Administration
THE HOUSE OF REPRESENTATIVES
House of Representa-
the ‘‘Drug
The Federal Government
Department of Health and Human Services
uct
the
Committee
Medicaid
Ways and Means
Health Affairs
VERTISEMENTS
Senate
the Committee on Energy and Commerce
PERSON (2)
SPANBERGER
NUNN
Topic Classifications
congressional legislation
95.3%
government oversight
46.5%
public health
46.2%
Extracted Keywords
advertising
medication
drugs
brand
pricing
consumer
prescription
drug
consumers
pharmaceutical
medicare
price
published
budget office
spending
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20231106125743Z
- Producer
- Acrobat Distiller 23.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20231104233808-04'00'
Sentiment
Polarity
Positive
0.120
Subjectivity
39%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.